mailchi.mp/easloffice/easl-studio-s4e18-10-may-2537665?e=4283be27e8 ... See MoreSee Less
Promoting Liver Health: an urgent call for action at WHOOn 22 May 2023, policymakers, thought leaders, Permanent Mission Representatives to the UN, WHO staff, and people affected by liver disease will gather at the EASL Office in Geneva for the invitation...
Rising obesity rates combined with unhealthy habits developed during the pandemic has led to an increase in some concerning diseases affecting the liver that has clinicians concerned. Check out this interactive interview with HCPLive, where Dr. Alkhouri discusses his use of the FibroScan® technology to improve care of patients with NAFLD and NASH at Arizona Liver Health.
👉Watch the interview here: www.hcplive.com/view/alkhouri-improving-nash-diagnosis-fibroscan ... See MoreSee Less
The future of diagnosing and monitoring NAFLD/NASH could be #noninvasive.
Learn more about that topic by reading the full article published in Pharma Technology Focus magazine.
#FibroScan® is mentioned as a non-invasive technology used for detecting and diagnosing #NAFLD in high-risk individuals, including type 2 diabetes patients.
#NASH #liverhealthmatters ... See MoreSee Less
Interesting research by BioMed Central, where they concluded that non-alcoholic fatty liver disease in haemochromoatosis patients with iron overload and HFE p.C282Y/p.C282Y, is associated with higher ferritin and greater Type 2 diabetes prevalence. You can read the open access article here - bmcgastroenterol.biomedcentral.com/articles/10.1186/s12876-023-02763-x ... See MoreSee Less
'Understanding Haemochromatosis', interview on Today with Claire Byrne, RTE 1 with Dr. Maire Finn, GP, Co. Clare discussing #haemochromatosis. To listen back to today's interview cllip, you can play the clip here: www.rte.ie/radio/radio1/clips/22245484/ ... See MoreSee Less
Today is #WorldObesityDay.
Let's take this opportunity to talk about #obesity and raise awareness that it is a risk factor for #NAFLD (Non-Alcoholic Fatty Liver Disease).
NAFLD is characterized by an accumulation of hepatic fat caused by a poor diet and a sedentary lifestyle.
It is the most common chronic liver disease in the world. If not diagnosed early, it can progress into #NASH (Non-Alcoholic Steatohepatitis) and lead to irreversible damage such as cirrhosis or liver cancer.
On this #WorldObesityDay, it is important to break the taboos around obesity, improve understanding of the causes and support patients to limit the consequences and exposure to other chronic diseases.
#WOD2023 #liverdisease #liverhealthmatters
Learn more on liver health: www.echosens.com/liver-health/ ... See MoreSee Less
April is the American #Alcohol Awareness Month.
Alcohol abuse kill over 3 millions people in the world each year and 50% of cirrhosis (end-stage #liver disease) related mortality is attributable to alcohol.
📣During this month, let's send a wake up call to recognize the urgent need for early detection of liver disease due to alcohol and help people better understand the causes and treatments available.
👉Learn more: bit.ly/3zVr3nr
#Liverhealthmatters #FibroScan #liverdisease ... See MoreSee Less